Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties

Thumbnail
View/ Open

Show full item record

Author
McCubrey, James A.; Meher, Akshaya K.; Akula, Shaw M.; Abrams, Stephen L.; Steelman, Linda S.; LaHair, Michelle M.; Franklin, Richard A.; Martelli, Alberto M.; Ratti, Stefano; Cocco, Lucio; Barbaro, Fulvio; Duda, Przemysław; Gizak, Agnieszka
URI
http://hdl.handle.net/10342/11681
Subject
 TP53; pancreatic cancer; drug sensitivity 
Date
2022-04-27
Citation:
APA:
McCubrey, James A., & Meher, Akshaya K., & Akula, Shaw M., & Abrams, Stephen L., & Steelman, Linda S., & LaHair, Michelle M., & Franklin, Richard A., & Martelli, Alberto M., & Ratti, Stefano, & Cocco, Lucio, & Barbaro, Fulvio, & Duda, Przemysław, & Gizak, Agnieszka. (April 2022). Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties. Aging, (14:8), p.3365-3386. Retrieved from http://hdl.handle.net/10342/11681

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A., and Meher, Akshaya K., and Akula, Shaw M., and Abrams, Stephen L., and Steelman, Linda S., and LaHair, Michelle M., and Franklin, Richard A., and Martelli, Alberto M., and Ratti, Stefano, and Cocco, Lucio, and Barbaro, Fulvio, and Duda, Przemysław, and Gizak, Agnieszka. "Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties". Aging. 14:8. (3365-3386.), April 2022. November 29, 2022. http://hdl.handle.net/10342/11681.
Chicago:
McCubrey, James A. and Meher, Akshaya K. and Akula, Shaw M. and Abrams, Stephen L. and Steelman, Linda S. and LaHair, Michelle M. and Franklin, Richard A. and Martelli, Alberto M. and Ratti, Stefano and Cocco, Lucio and Barbaro, Fulvio and Duda, Przemysław and Gizak, Agnieszka, "Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties," Aging 14, no. 8 (April 2022), http://hdl.handle.net/10342/11681 (accessed November 29, 2022).
AMA:
McCubrey, James A., Meher, Akshaya K., Akula, Shaw M., Abrams, Stephen L., Steelman, Linda S., LaHair, Michelle M., Franklin, Richard A., Martelli, Alberto M., Ratti, Stefano, Cocco, Lucio, Barbaro, Fulvio, Duda, Przemysław, Gizak, Agnieszka. Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties. Aging. April 2022; 14(8) 3365-3386. http://hdl.handle.net/10342/11681. Accessed November 29, 2022.
Collections